Table 2

Comparison of adverse events between placebo and active-drug arms of a trial of interferon-β-1a in patients with rheumatoid arthritisa

Adverse event

Drug (n = 16) No. (%)

Placebo (n = 6) No. (%)


Flu-like symptoms

Arthralgias/myalgias

6 (38)

2 (33)

Headache

8 (50)

1(17)

Fatigue/weakness

2 (13)

1(17)

Subjective fevers

3 (19)

0

Chills

6 (38)

0

Hypertension

3 (19)

0

Oral ulcers

3 (19)

0

Pain at injection site

1 (6)

0

Insomnia

0

1(17)

Depression/anxiety

1 (6)

1(17)

Menstrual irregularities

1 (6)

1(17)

Rash

3 (19)

1(17)

Wheeze

2 (13)

0

Gastrointestinal distress

Nausea

2 (13)

0

Abdominal pain

2 (13)

0

Diarrhea

0

1 (17)

Infections

Upper respiratory infection

2 (13)

3 (50)

Sinus infection

0

1(17)

Infection on right arm

1 (6)

0

Perineal fungal rash

1 (6)

0

Varicella-zoster rash

1 (6)

0

Other (single reports only)

9 (56) *

5 (83) **


aAll the differences in occurrences were tested by Fisher's exact test (one-tailed) and were statistically not significant. *Hypoglycemia, paresthesia on left side of face, contact dermatitis, photosensitivity, flare of arthritis, cramping in toes, dysphagia, nasal lesion, blurred vision. **Hematuria, burn on arm, tachycardia, paresthesia on left leg, lymphadenopathy.

Genovese et al. Arthritis Res Ther 2004 6:R73   doi:10.1186/ar1026

Open Data